about
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and i...
Read More
50.93
0.83
(1.66%)
355.8K
XNYS Volume
XNYS 29 Jan, 2026 9:46 AM (EST)
Board Meeting
The next board meeting for GSK PLC (ADR) is on 05 Feb 2026 for the purpose of GSK PLC Fourth Quarter Earnings Results for 2025
See details
Medium Financial Strength
Affordable Valuation
Technically Moderately Bullish
Turnaround Potential
These stocks have average financials with good valuations and momentum, indicating turnaround potential
View Similar
Embed DVM
GSK PLC (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..